OpenAlex
PricingAboutJobs
Log inGet started
Work

Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells.

PubMed

Year: 1997
Type: article
Source: PubMed
Authors: M A Guvakova, E Surmacz
Institution: Thomas Jefferson University
Language: English

Topic: Growth Hormone and Insulin-like Growth Factors
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: tamoxifen, IGF-1 receptor, IGF-IR signaling, breast cancer, MCF-7 cells, IRS-1, phosphatidylinositol 3-kinase, Shc, Grb2, tyrosine phosphorylation, antiestrogens, cell growth inhibition, insulin-like growth factor I, receptor down-regulation
SDG: Good health and well-being

Open Access status: closed

Funder: National Institute of Diabetes and Digestive and Kidney Diseases
Award: IGF 1R IN BREAST CANCER
OpenAlex ID: W1497802607
FWCI: 8.304
Cites:
Cited by: 158
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms